蛋白的产生只见于肝细胞性肝癌。
Alphafetoprotein production is only seen in liver cell carcinoma.
目的探讨超声衰减成像技术定量评估肝细胞性肝癌患者肝功能储备的价值。
Objective to investigate the value of quantitative assessment of hepatic fibrosis in predicting hepatic functional reserve of patients with hepatocellular carcinoma (HCC).
肝细胞性肝癌是临床常见的一种恶性肿瘤，但目前对其发病机制仍不明确。
Hepatocellular carcinoma is one kind of clinical common malignant tumor, however, at present it was still not clear about its pathogenesis.
结论：提示P16蛋白的表达与肝细胞性肝癌的分化程度有关，与肿瘤大小有关。
Conclusion: the expression of P16 protein is related to the degree of the differentiation but not related to the size of the humors.
目的：检测MCP-1在肝细胞性肝癌中表达的状况，分析其与肿瘤血管新生的关系。
Objective:To investigate the expression of monocyte chemoattractant protein-1(MCP-1) in hepatocellular carcinoma and the clinical significance.
将来要改善肝细胞性肝癌化疗患者预后的措施应考虑同时给予减少病毒负荷量的抗病毒辅助治疗。
Future strategies to improve the prognosis of HCC patients undergoing chemotherapy should consider supportive therapy that incorporates antiviral therapies to reduce HBV viral load.
肝细胞性肝癌是发病和死亡的常见原因。对于不能手术切除肿瘤的患者，予全身化疗是标准治疗方案之一。
HCC is a common cause of morbidity and mortality. For patients who are not candidates for curative surgery, systemic chemotherapy is one of the standard treatments.
目的探讨MAGE-1基因编码的肿瘤相关抗原作为肝细胞性肝癌（HCC）主动免疫治疗攻击靶点的可能性。
Objective To explore the possibility of tumor associated antigen encoded by MAGE-1gene used as a tarest for immunotherapy in HCC patients.
方法：用s -P免疫组织化学方法分别检测71例肝细胞性肝癌(HCC)15例肝硬化及10例正常肝脏pten蛋白表达。
Methods 71 cases of hepatocellular carcinoma (HCC), 15 cases of hepatocirrhosis, 10 cases of normal liver were selected for PTEN protein expression by S-P immunohistochemistry.
其中肝细胞性肝癌77例(84.6%)，胆管癌9例(9.9%)，混合细胞性肝癌2例(2.2%)和肝母细胞瘤3例(3.3%)。
Among all the cases studies, 77 (84.6%) were of hepatocellular carcinoma, 9 (9.9%) of cholangiocarcinoma, 2 (2.2%) of mixed cell carcinoma, and 3 (3.3%;) of hepatoblastoma.
A 22鼠腹水肝癌细胞和鼠正常肝细胞膜脂的运动性。
A22 mouse ascites cell membrane lipids and those of the control cells.
化学诱导剂产生的肝癌模型与人肝癌有着相似性，所以这些数据对研究肝细胞癌的机制有重要意义。
As the HCC model has the similarity to human HCC, these data have important implications in understanding the mechanism of HCC.
持续病毒学应答可以降低肝硬化和肝病并发症的发生，降低肝癌(肝细胞性癌)和死亡的发生率。
Sustained virologic response can result in decreased cirrhosis and complications of liver disease, decreased rates of liver cancer (hepatocellular carcinoma), and decreased mortality.
原发性肝细胞癌、转移性肝癌、局灶性结节增生、炎性假瘤在MRSP各期中表现不同。
Primary hepatic carcinoma, hepatic metastases, focal nodular hyperplasia, and inflammatory pseudotumor were presented as different MR features on each phase of MRSP.
结论本研究所建立的裸鼠移植性人肝细胞肝癌模型成瘤率高，移植瘤生长良好，便于MRI观察，是一种适合于分子影像学研究的动物模型。
Conclusion The nude mouse model with FHCC, with ideal implantation and tumor growth rate, was convenient for MRI observation and suitable for molecular imaging research of human HCC.
肝细胞肝癌具有起病隐匿，恶性程度高，侵袭性生长快速，治疗后易复发，病死率高等特点。
Hepatocellular carcinoma is also a high malignancy with insidious onset, invasive fast-growing, high recurrence rate and fatality.
目的：探讨肝细胞肝癌超声造影峰值强度与血管生成的相关性，以期为临床提供无创性血管生成的评估指标。
Purpose: in order to assess the angiogenesis of hepatocellular carcinoma, the peak intensity in contrast ultrasonography of the lesions was compared with the findings of immunohistochemistry.
近年来，我国原发性肝细胞癌的发病率有上升的趋势。一百年来，根治性手术切除被公认为肝癌获得根治的最好手段。
The morbidity of primary hepatocellular carcinoma has been increasing in recent years, so it is emergent to perform research work on the prevention and treatment of primary hepatocellular carcinoma.
目的：探讨肝细胞肝癌超声造影峰值强度与血管生成的相关性。
Objective To evaluate the value of contrast enhanced ultrasound in diagnosis of small focal liver lesions in an early stage.
目的：探讨肝细胞肝癌超声造影峰值强度与血管生成的相关性。
Objective To evaluate the value of contrast enhanced ultrasound in diagnosis of small focal liver lesions in an early stage.
应用推荐